FIELD: medicine.
SUBSTANCE: present group of inventions refers to medicine, namely cardiology and concerns improvement in cardiac function by prolonged release of neuregulin. That is ensured by applying a prolonged-release composition providing neuregulin release for 1-24 hours daily.
EFFECT: such prolonged introduction of neuregulin reduces ventricular remodelling and improves cardiac function ensured by expression of genes determining cardiac myocyte growth and differentiation.
26 cl, 5 tbl, 8 ex
Authors
Dates
2012-08-10—Published
2006-12-29—Filed